logo

For the Inventor, By the Inventor

Ile-Bizard, Canada

Serge St Pierre

This inventor holds 9 USPTO granted patents. Top assignees: Conjuchem, Inc., Haemacure Corporation. Active years: 1999-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Serge St Pierre. Retrieved from https://idiyas.com/inventor/serge-st-pierre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9

% Patents Active = 33.3

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 638(Granted Patents)


Location History:

  • Ile Bizard, CA (1999 - 2005)
  • Ile Bezard, CA (2011 - 2012)

Company Filing History:

goldMedal8 out of 28 
 
Conjuchem, Inc.
 patents
silverMedal1 out of 4 
 
Haemacure Corporation
 patents

Years Active: 1999-2012

Loading Chart...
9 patents (USPTO):Explore Patents
1. 8093206 - Methods involving long lasting synthetic exendin-4 peptide conjugates (2012-01-10),
2. 8084414 - Methods involving long lasting synthetic exendin-4-peptide conjugates (2011-12-27),
3. 8080516 - Long lasting synthetic exendin-4 peptide conjugates (2011-12-20),
4. 6887849 - Long lasting synthetic glucagon-like peptide {GLP-1} (2005-05-03),
5. 6821949 - Long lasting synthetic glucagon-like peptide (GLP-1) (2004-11-23),
6. 6593295 - Long lasting insulinotropic peptides (2003-07-15),
7. 6514500 - Long lasting synthetic glucagon like peptide {GLP-!} (2003-02-04),
8. 6329336 - Long lasting insulinotropic peptides (2001-12-11),
9. 5856308 - Artificial collagen (1999-01-05),

Sure, I can help you with that. Here is the article about inventor Serge St Pierre:

Title: The Innovative Journey of Inventor Serge St Pierre

Introduction:

Inventor Serge St Pierre, hailing from Ile Bezard, CA, is a visionary in the field of innovative medical advancements. With a total of 9 patents to his name, Serge has made significant contributions to the world of healthcare through his groundbreaking inventions.

Latest Patents:

Among his latest patents, Serge St Pierre has introduced revolutionary methods involving long-lasting synthetic exendin-4 peptide conjugates. These modified insulinotropic peptides have the unique ability to form peptidase-stabilized insulinotropic peptides that can covalently bond with blood components to create conjugates. These conjugates, whether formed in vivo or ex vivo, hold immense potential in treating individuals with diabetes and other related diseases.

Career Highlights:

Throughout his career, Serge St Pierre has left an indelible mark on the industry, working with esteemed companies like Conjuchem, Inc. and Haemacure Corporation. His innovative approach to medical research and development has not only garnered acclaim but has also led to tangible advancements in the field of healthcare.

Collaborations:

In his journey of innovation, Serge St Pierre has collaborated with notable individuals such as Benoit L'Archeveque and Darren L. Holmes. Together, they have shared a passion for pushing the boundaries of medical science and bringing forth solutions that have the potential to improve the lives of countless individuals.

Conclusion:

Serge St Pierre's unwavering dedication to innovation and his penchant for developing groundbreaking medical solutions have established him as a trailblazer in the industry. Through his patents and collaborations, Serge continues to inspire the next generation of inventors and researchers to push the limits of what is possible in the realm of healthcare.

If you need further details or have any specific requirements, feel free to let me know!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…